Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02332174

Ligand	Ligand name	Chain	PDB	Tanimoto
MGQ	7-BENZYL GUANINE MONOPHOSPHATE	A,E	2V8X	0.74
YE7	IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE	A	2P98	0.74
FRT	N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE	A	2W05	0.71
GSS		A	1AP1	0.72
G14	2-phenyl-1H-imidazole-4-carboxylic acid	A,B	3GRJ	0.71
IZ1	N-[(1S)-2-{4-[(5S)-1,1-dioxido-3-oxoisothiazolidin-5-yl]phenyl}-1-(4-phenyl-1H-imidazol-2-yl)ethyl]-3-(trifluoromethyl)benzenesulfonamide	A	2VEU	0.7
ED2	N-benzyl-N-(2-{(4-cyanophenyl)[(1-methyl-1H-imidazol-5-yl)methyl]amino}ethyl)-1-methyl-1H-imidazole-4-sulfonamide	B	3E32	0.71
I17	2-[TRANS-(4-AMINOCYCLOHEXYL)AMINO]-6-(BENZYL-AMINO)-9-CYCLOPENTYLPURINE	A	1G5S	0.71
FTB	N-{4-[1-(2-FLUOROBENZYL)-3-BUTYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YLMETHYL]-PHENYL}-ACETAMIDE	A	1NHX	0.72
MGV	P-FLUORO-7-BENZYL GUANINE MONOPHOSPHATE	A,E	2V8Y	0.73
FR2	1-((1R)-1-(HYDROXYMETHYL)-3-PHENYLPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1NDW	0.73
120	2-(2-OXO-1,2-DIHYDRO-PYRIDIN-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	B	1GI7	0.71
120	2-(2-OXO-1,2-DIHYDRO-PYRIDIN-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	H,I	1GHV	0.71
120	2-(2-OXO-1,2-DIHYDRO-PYRIDIN-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	A	1GHZ	0.71
SC3	7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE	A,B,C,D	2AJ8	0.8
349	5-{[4-{[2-(pyrrolidin-1-ylsulfonyl)benzyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-1,3-dihydro-2H-indol-2-one	A	3ET7	0.74
N31	N-[3-(1H-benzimidazol-1-yl)propanoyl]glycyl-L-alanyl-L-alaninamide	A	3EXB	0.71
LIR	2-[(3S)-3-AMINOPIPERIDIN-1-YL]-1-(2-CYANOBENZYL)-5-METHYL-4,6-DIOXO-3,4,5,6-TETRAHYDROPYRROLO[3,4-D]IMIDAZOL-1-IUM	A	2I3Z	0.71
TSX	N-[4-(1-ALLYL-3-BUTYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YLMETHYL)-PHENYL]-ACETAMIDE	A	1M51	0.74
IZ5	N-{(1S)-2-{4-[(5S)-1,1-dioxido-3-oxoisothiazolidin-5-yl]phenyl}-1-[4-(3-phenylpropyl)-1H-imidazol-2-yl]ethyl}-3-fluorobenzenesulfonamide	A	2VEY	0.7
N2G		A,P,T	2W8K	0.71
N2G		A,P,T	2W8L	0.71
OLO	OLOMOUCINE	A	4ERK	0.71
OLO	OLOMOUCINE	C	1W0X	0.71
UN8	N-(4-{[3-BUTYL-1-(2-FLUOROBENZYL)-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL]METHYL}PHENYL)-1-METHYL-1H-IMIDAZOLE-4-SULFONAMIDE	A,B	2GMV	0.76
T15	2-{3-[(benzylsulfonyl)amino]-6-methyl-2-oxopyridin-1(2H)-yl}-N-({1-[2-(tert-butylamino)-2-oxoethyl]-4-methyl-1H-imidazol-5-yl}methyl)acetamide	A,B	3C1K	0.81
FRV	4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE	A	2W06	0.72
ED7	N-benzyl-N-(2-{(4-cyanophenyl)[(1-methyl-1H-imidazol-5-yl)methyl]amino}ethyl)-2-methylbenzenesulfonamide	B	3E33	0.73
XIH	2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE	A	2GBI	0.76
HDT	4-[(4-IMIDAZO[1,2-A]PYRIDIN-3-YLPYRIMIDIN-2-YL)AMINO]BENZENESULFONAMIDE	A	1OIT	0.72
EMU	N-BENZYL-9H-PURIN-6-AMINE	A	1W1S	0.71
GSR		A	1AF1	0.72
BPG	9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE	A,B	1QHI	0.79
C02	4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE	B,C	1KTT	0.7